Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery

Clinical data support the feasibility and safety of adeno-associated viral (AAV) vectors in gene therapy applications. Despite several clinical trials of AAV-based gene transfer for hemophilia B, a unique set of obstacles impede the development of a similar approach for hemophilia A. These include (...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Harrison C, Wright, J Fraser, Zhou, Shangzhen, Lytle, Allison M, Shields, Jordan E, Spencer, H Trent, Doering, Christopher B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362354/
https://www.ncbi.nlm.nih.gov/pubmed/26015976
http://dx.doi.org/10.1038/mtm.2014.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362354/
https://www.ncbi.nlm.nih.gov/pubmed/26015976
http://dx.doi.org/10.1038/mtm.2014.36

Ejemplares similares